Production (Stage)
Gemina Laboratories Ltd.
GLAB
CNSX
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 11.99% | -77.21% | 26.87% | 40.20% | 51.80% |
| Total Depreciation and Amortization | 4.55% | 7.61% | 6.93% | 26.45% | 43.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -16.33% | 255.73% | -72.93% | -16.64% | -41.86% |
| Change in Net Operating Assets | 658.86% | 11.73% | 17.85% | 6.65% | 79.61% |
| Cash from Operations | 103.71% | -513.11% | 35.85% | 69.72% | 61.08% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 8.33% | -- | -- | -- |
| Total Debt Issued | -- | -- | -75.00% | -- | -- |
| Total Debt Repaid | 62.45% | -18.18% | -16.67% | -33.66% | -64.88% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 46.69% | -- | -- | -- | 75.58% |
| Cash from Financing | -102.01% | 15.82% | -93.80% | 2,468.87% | -73.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,900.00% | -1,957.14% | -46.49% | 121.10% | -99.93% |